Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over

  • Technology appraisal guidance
  • TA1051
  • Published: 

History

Documents created during the development process.

Final draft guidance

Declaration of interests

Draft guidance

Committee meetings

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6170